Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Hrtwr Intrntl Inc (HTWR)

Hrtwr Intrntl Inc (HTWR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Hrtwr Intrntl Inc 500 OLD CONNECTICUT PATH FRAMINGHAM MA 01701

www.heartware.com P: 508-739-0873

Description:

HeartWare International, Inc. along with its subsidiaries is a medical device company focused on developing and commercializing small implantable pumps for the treatment of chronic and end-stage heart failure. Its principle product, the HeartWare Ventricular Assist System, includes a left ventricular assist device, related accessories and surgical tools and is designed to provide circulatory support for patients with advanced heart failure. The company is also developing the Miniaturized Ventricular Assist Device focused on minimally invasive implantation techniques. HeartWare is also developing a portfolio of further miniaturized devices, implantable by progressively less invasive surgery. The Company's corporate headquarters are in Framingham, Massachusetts and its operating and manufacturing activities are based in Miami Lakes, Florida.

Key Statistics

Overview:

Market Capitalization, $K 1,018,600
Shares Outstanding, K 17,560
Annual Sales, $ 276,840 K
Annual Net Income, $ -72,780 K
Last Quarter Sales, $ 68,720 K
Last Quarter Net Income, $ -10,880 K
60-Month Beta 0.30
% of Insider Shareholders 2.40%
% of Institutional Shareholders 85.13%

Growth:

1-Year Return -30.12%
3-Year Return -26.23%
5-Year Return -7.98%
5-Year Revenue Growth 401.89%
5-Year Earnings Growth 33.18%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.62 on 07/28/16
Latest Earnings Date 08/04/16
Earnings Per Share ttm -3.27
EPS Growth vs. Prev Qtr 54.74%
EPS Growth vs. Prev Year 8.51%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

HTWR Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -31.68%
Return-on-Assets % -12.59%
Profit Margin % -26.29%
Debt/Equity 1.01
Price/Sales 3.68
Price/Cash Flow N/A
Price/Book 6.01
Book Value/Share 9.64
Interest Coverage 0.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar